Liquidia Technologies Inc (LQDA) is experiencing selling pressure, leading to a decline in its stock price.
Shares of Liquidia Technologies Inc (NASDAQ:LQDA) are down 2.22% today as investors react to several concerning developments regarding the company's performance and outlook.
Investor takeaway: Investors should be aware of the risks tied to Liquidia's heavy reliance on its lead product, Yutrepia, especially amid ongoing patent disputes and a limited pipeline.
Advertisement
Liquidia Technologies Inc
LQDA.US
LQDA.US
Liquidia Technologies Inc
WealthAwesomeMarket cap
$6.13B
P/E
46.9x
52W high
$93.61
52W low
$21.14
1W change
-0.97%
Beta
0.54
Analyst Price Targets
Based on 10 analysts covering LQDA · as of Sep 17, 2026
Wall Street analysts forecast LQDA stock price to rise 57.4% over the next 12 months.
Consensus
Buy4.30 / 5.00
Avg. Target
C$107.75
+57.4% Upside
Current Price
C$68.45
Last close
Analyst Breakdown (10 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LQDA's historical volatility
30-Day Vol
56.5%
Annualized
90-Day Vol
59.8%
Annualized
Trend (90d)
-33.3%
Annualized drift
90d Mean
C$60.71
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$65.73 | C$54.09 – C$79.87 |
| 60 trading days | C$63.17 | C$47.96 – C$83.21 |
| 90 trading days | C$60.71 | C$43.32 – C$85.09 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Liquidia's stock down 2.22% today
The stock has dropped 13.9% over the past month, underperforming both its industry and the broader market.
Bull case
Yutrepia is showing promising sales growth and gaining traction in the market. If Liquidia can successfully expand its indications, this could create a solid revenue stream for the company.
Bear case
Liquidia's heavy dependence on Yutrepia poses significant risks, particularly due to ongoing patent litigation and a lack of diversification in its product pipeline.
Liquidia's Recent Performance
Advertisement
Liquidia Technologies Inc has seen its stock price fall by 2.22% today, adding to a troubling trend where the stock has lost 13.9% over the past month. This underperformance has raised concerns among investors, especially after the company reported second-quarter results that, while beating consensus estimates, failed to impress the market.
Concerns Over Yutrepia and Patent Disputes
Liquidia's lead product, Yutrepia, is a key revenue driver, but the company's heavy reliance on this single product raises significant risks. The ongoing patent dispute with United Therapeutics could lead to negative outcomes that may affect Yutrepia's market potential. Investors are cautious as the company navigates these challenges, along with a limited pipeline for future growth.
Market Outlook and Valuation
Despite Yutrepia's promising sales, Liquidia's stock trades at a price/sales ratio much higher than the industry average, suggesting potential overvaluation. Additionally, recent downward revisions in earnings estimates for 2026 and 2027 indicate that analysts are increasingly worried about the company’s near-term prospects, which is contributing to the stock's decline.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
